Anticancer agent 230 - HY-164064
Nur noch %1 verfügbar
Catalog #
HY-164064
Ab
52,00 €
Anticancer agent 230 (example 65) is a caseinolytic protease P (ClpP) activator with anticancer activity. Anticancer agent 230 is able to induce the degradation of mitochondrial proteins in SUM159 and MDA-MB-231 triple-negative breast cancer cells in a time-dependent manner[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-164064/Anticancer-agent-230-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| CAS | 2485052-87-5 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 390.87 |
| Solubility | DMSO : 50 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | ClpP |
| Application: | Cancer-programmed cell death |
|---|